Skip to content

Drug interactions

Eplerenone + Tucatinib

Severity: Moderate

Eplerenone and Tucatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib inhibits CYP3A and may increase eplerenone exposure, increasing the risk of hyperkalemia.

What this interaction means in plain words

Eplerenone and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Eplerenone belongs to Cardiovascular; Tucatinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Tucatinib inhibits CYP3A4 metabolism of eplerenone.

What to do

Monitor serum potassium and renal function closely and reduce the eplerenone dose per labeling, or choose an alternative.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eplerenone and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Eplerenone with Tucatinib?

MediHelp rates the interaction as moderate. Eplerenone and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tucatinib inhibits CYP3A and may increase eplerenone exposure, increasing the risk of hyperkalemia.

How serious is the interaction between Eplerenone and Tucatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium and renal function closely and reduce the eplerenone dose per labeling, or choose an alternative.

What other medicines interact with Eplerenone?

MediHelp also lists interactions of Eplerenone with, for example, Amiloride, Atazanavir, Clarithromycin. The full list is on the Eplerenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in